Skip to main content
OpenTrials
Completed

NCT Number: NCT03848884

Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adherence, Patient Behavior Health Behavior Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

About this study

To evaluate if a monthly adherence monitoring and education service impacts the percent of patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA) medications based on star ratings. It will also evaluate patient satisfaction of the adherence monitoring and education service, using a standard questionnaire.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC < 80%
  • Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor)

Exclusion criteria

  • Patients who are enrolled in MedSync or Autorefill program
  • Patients who are lost to follow-up
  • Incomplete/missing documentation of an encounter
  • Prisoners, children

Treatment and study plan

Adherence monitoring and education

Behavioral

Standardized medication counseling and education combined with individual patient customized guidance and counseling - administered monthly.

Primary outcomes

  1. Adherence in oral diabetes medications determined by star ratings

    Time frame: Baseline to 6 months

    Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.

  2. Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratings

    Time frame: Baseline to 6 months

    Determine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.

Secondary outcomes

  1. Change in proportion of days covered (PDC)

    Time frame: Baseline to 6 months

    Determine change in PDC after monthly follow-up on medication adherence and education; pharmacy analytics determines patient PDC in normal practice. The mean PDC for each patient at the end of the six-month study period will be compared to the baseline using a student t-test.

Other outcomes

  1. Satisfaction with education and monitoring service

    Time frame: 6 months

    "Patient Satisfaction Survey" includes an 8-item 5-point likert scale (Strongly Disagree, Disagree, Neutral, Agree, Strongly Agree) about whether or not the pharmacist provided adequate education to the patient, whether or not the patient feels his/her health benefited from the service, and if the patient would recommend the service. The "Patient Satisfaction Survey" will be analyzed using descriptive statistics to determine how satisfied patients were with the medication adherence monitoring and education service.

Sponsors and collaborators

Lead sponsor

Virginia Commonwealth University

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Feb 21, 2019
Registry last updated
Oct 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.